FutureChem Co (XKRX:220100) ROCE % : -1.76% (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is FutureChem Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. FutureChem Co's annualized ROCE % for the quarter that ended in Dec. 2024 was -1.76%.

FutureChem Co ROCE % Historical Data

The historical data trend for FutureChem Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FutureChem Co ROCE % Chart

FutureChem Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

-43.02

-3.33

-17.84

-8.63

-13.68

FutureChem Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															-8.96	-10.17	-20.48	-19.62	-1.76

FutureChem Co ROCE % Calculation

FutureChem Co's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-8745.789	/	( ( (72833.182 - 3640.46)	+	(74421.441 - 15775.845) )	/ 2 )
	=	-8745.789	/	( (69192.722	+	58645.596)	/ 2 )
	=	-8745.789	/	63919.159
	=	-13.68 %

FutureChem Co's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	-1173.216	/	( ( (77831.713 - 3338.22)	+	(74421.441 - 15775.845) )	/ 2 )
	=	-1173.216	/	( ( 74493.493	+	58645.596 )	/ 2 )
	=	-1173.216	/	66569.5445
	=	-1.76 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

FutureChem Co (XKRX:220100) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

FutureChem Co ROCE % Related Terms

Thank you for viewing the detailed overview of FutureChem Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

FutureChem Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FutureChem Co Ltd (XKRX:220100) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

2Floor, 21, Yeonmujang 3-gil, Seongdong-gu, Seoul, KOR, 04782

Website

http://www.futurechem.co.kr

FutureChem Co Ltd is a radiopharmaceuticals company engaged in manufacturing related precursors chemicals, automatic synthesizer, and synthesis reagents and develops & commercializes new traces with research and development. It offers radiopharmaceuticals for diagnosing cancers, and Alzheimer's diseases; and automation modules and disposable goods, such as disposable cassettes, reagent kits, and radio-caps. It also provides peptide-based radiopharmaceuticals for radio-metal chelation and click reaction; linkers for bio-conjugation using copper-free/mediated click reaction. In addition, the company is involved in the research and development of radioisotope labeling technology; and automation devices. Further, it offers amino acids and reagents for peptides; and ionic liquids.

FutureChem Co Headlines

No Headlines